American Academy of Neurology® April 2019LikeFollowShareA First in Human Study of PBT434, a Novel Small Molecule Inhibitor of α-Synuclein Aggregation (S4.001)https://www.neurology.org/doi/10.1212/WNL.92.15_supplement.S4.001Share your feedbackQuestions (0)Post questionYour question will be sent privately to Alterity Therapeutics. The company may choose to make this question public.Start the conversationAsk Alterity Therapeutics a question about this update.DiscoverShare your feedbackDiscover